Parliament Workbench
Data: Motions & questions to 19 Nov 2026 · Votes to 12 Nov 2026

Standard Motion · S4M-13656 · Session 4

Novel Treatment for Breast Cancer

Lodged by Dr Richard Simpson Lab Lodged 25 Jun 2015 20 supporters

The motion

That the Parliament understands that the use of intrabeam radiotherapy has the potential to substantially reduce the burden of radiotherapy in the treatment of women with breast cancer; recognises that this novel treatment was first tried at the Middlesex Hospital in 1998 and is now being undertaken routinely in the US, Germany, Australia, France and other countries; welcomes the guidance issued by the National Institute for Health and Care Excellence in July 2014 recommending a single dose intrabeam radiotherapy at the time of surgery to replace 15 sessions of post-operative radiotherapy; appreciates that this decision was taken after a randomised controlled trial led by University College London, the TARGIT-A trial, which was published in 2010 and showed at five year follow up in 2014 that results were not inferior to the previous 15 session treatment, and invites the Scottish Government to support the implementation of this new therapy for the benefit of patients and in the expectation of substantial savings in resource to the NHS.

Signatures by party

20 MSPs besides the lodger · 5 from other parties
Lab 15SNP 3Con 2

Party on the day each MSP signed. Signing a motion is voluntary and not whipped. Who signs whose motions

Vote

No recorded vote on this motion. Most motions are never debated, and many that are debated are agreed without a division. Vote records are published from 2011.

Supporters

20 MSPs

Lab 15 SNP 3 Con 2

Show all 20 supporters by party

Lab 15

SNP 3

Con 2

Party shown is each supporter’s party when the motion was published.

In the Official Report

No contribution in the Official Report cites S4M-13656 by reference.